Genlabs Survoglutide 10mg is a synthetic peptide that acts as a dual agonist of GLP‑1 (glucagon-like peptide-1) and glucagon receptors. It is mainly studied in research for its potential effects on blood sugar regulation, metabolism, and energy balance.

How It Works?

Survoglutide binds to GLP‑1 and glucagon receptors in the body:

Glucagon receptor activation: Influences energy metabolism and helps the body use stored energy.

By acting on these two pathways simultaneously, Survoglutide is studied for metabolic research, weight management studies, and glucose regulation models.

Dosage :

Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL (5000 mcg/mL) concentration.

Typical weekly range: 0.6–6.0 mg once weekly (gradual titration over 10–12 weeks).

Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg on a U‑100 insulin syringe.

Storage: After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); protect from light.

Benefits :

• Supports blood sugar regulation in experimental models
• Helps study energy balance and metabolism
• Useful for weight management and appetite research
• Allows investigation of dual GLP‑1 and glucagon receptor activity
• Serves as a research tool for metabolic studies

Side Effects :

• Potential metabolic disturbances in uncontrolled settings.

Conclusion :

Survoglutide 10 mg is a research-grade peptide studied for its dual action on GLP‑1 and glucagon receptors. It is valuable in experiments focused on blood sugar control, energy metabolism, and metabolic research.